Prognosis of Patients with Recurrent or Advanced Lung Cancer According to the Status of Epidermal Growth Factor Receptor

被引：0
|
作者：
Ito, K. [1 ]
机构：
[1] Kyoto Yamashiro Med Ctr, Kizugawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Epidermal growth factor receptor; Advanced lung cancer; Postoperative recurrence treatment;
D O I：
10.1016/j.jtho.2019.08.2058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.01-85
引用
收藏
页码：S944 / S944
页数：1
相关论文
共 50 条
  • [21] Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer
    Na, Im Il
    Kim, Hye-Ryoun
    Lee, Jin Kyung
    Park, Sun Hoo
    Kim, Cheol Hyeon
    Koh, Jae Soo
    Baek, Hee Jong
    Choe, Du Hwan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (03) : 373 - 378
  • [22] Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non-Small-Cell Lung Cancer
    Sun, Hai-bo
    Ou, Wei
    Li, Yin
    Fang, Qin
    Qin, Jianjun
    Zhang, Liang
    Wang, Si-yu
    CLINICAL LUNG CANCER, 2013, 14 (04) : 376 - 382
  • [23] Epidermal growth factor receptor mutation status in advanced non-small cell lung cancer: A single institution experience
    Vaguliene, Neringa
    Zemaitis, Marius
    Sarauskas, Valdas
    Vitkauskiene, Astra
    Miliauskas, Skaidrius
    Sakalauskas, Raimundas
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [24] Epidermal Growth Factor Receptor Status in Stages of Resected Non-Small Cell Lung Cancer Implications for Treatment with Epidermal Growth Factor Receptor Inhibitors
    Berardi, Rossana
    Santinelli, Alfredo
    Brunelli, Alessandro
    Onofri, Azzurra
    Pierantoni, Chiara
    Scartozzi, Mario
    Pisa, Eleonora
    Stramazzotti, Daniela
    Mazzanti, Paola
    Zuccatosta, Lina
    Gasparini, Stefano
    Sabbatini, Armando
    Cascinu, Stefano
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2011, 33 (04): : 196 - 204
  • [25] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer
    Xu, Jianlin
    Chu, Tianqing
    Jin, Bo
    Dong, Xue
    Lou, Yuqing
    Zhang, Xueyan
    Wang, Huiming
    Zhong, Hua
    Shi, Chunlei
    Gu, Aiqing
    Xiong, Liwen
    Zhao, Yizhuo
    Jiang, Liyan
    Zhang, Jie
    Han, Baohui
    CLINICAL LUNG CANCER, 2016, 17 (04) : 309 - 314
  • [26] Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine
    Garcia, Beatriz
    Neninger, Elia
    de la Torre, Ana
    Leonard, Idrissa
    Martinez, Rocio
    Viada, Carmen
    Gonzalez, Gisela
    Mazorra, Zaima
    Lage, Agustin
    Crombet, Tania
    CLINICAL CANCER RESEARCH, 2008, 14 (03) : 840 - 846
  • [27] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer
    Lin, Chia-Chi
    Yang, Chih-Hsin
    TARGETED ONCOLOGY, 2009, 4 (01) : 37 - 44
  • [28] PROGNOSTIC SIGNIFICANCE OF SYSTEMIC INFLAMMATORY RESPONSE AND EPIDERMAL GROWTH FACTOR RECEPTOR GENE STATUS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Togashi, Yosuke
    Masago, Katsuhiro
    Sakamori, Yuichi
    Kim, Young Hak
    Mishima, Michiaki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1012 - S1013
  • [29] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN ADVANCED LUNG ADENOCARCINOMA
    Chai, Chee Shee
    Liam, Chong-Kin
    RESPIROLOGY, 2015, 20 : 89 - 89
  • [30] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer
    Chia-Chi Lin
    Chih-Hsin Yang
    Targeted Oncology, 2009, 4 : 37 - 44
12345